CCND1 and non-small cell lung carcinoma: Other tumor markers that play an important role in lung carcinogenesis and are implicated in the treatment response of NSCLC patients should also be evaluated, namely cyclin D1, kRAS and EGFR (epidermal growth factor receptor).